J&J | JNJ - Pre Tax Profit

Stock Price
228.62
Daily Change
-1.23 -0.54%
Monthly
-5.93%
Yearly
46.44%
Q2 Forecast
222.63

J&J reported $7.82B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Abbott USD 2.39B 27M Mar/2026
Amgen USD 1.51B 2.41B Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
Baxter International USD -756M 877M Dec/2025
Bayer EUR -1.16B 735M Sep/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Biogen USD 377.7M 433.7M Mar/2026
Boston Scientific USD 700M 238M Dec/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
CONMED USD 29.25M 24.98M Dec/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Globus Medical USD 143.99M 44.18M Sep/2025
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Merck USD 3.42B 3.32B Dec/2025
Merit Medical Systems USD 51.06M 22.12M Dec/2025
Novartis USD 4.64B 445M Dec/2025
Pfizer USD 3.33B 290M Sep/2025
Regeneron Pharmaceuticals USD 1.04B 719.6M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teva Pharmaceutical Industries USD 753M 662M Mar/2026
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025
Zoetis USD 887M 15M Sep/2025